Purpose: To present a case of retinal arterial macroaneurysm in a 48–year–old male patient with systemic arterial hypertension. Case report: A 48–year–old male was admitted to our department because of progressive deterioration of visual acuity in his right eye. He reported diplopia and blurred central field vision. The patient was treated for systemic arterial hypertension and had no other known medical problems. Medical treatment, examination results, and therapy were presented in this case report. Conclusions: In the treatment of patients with retinal arterial macroaneurysm a holistic approach is important. In an attempt to optimize the final outcome of the patient's treatment, both the ocular symptoms and systemic risk factors should be treated. Therapeutic interventions for eyes with retinal arterial macroaneurysm include laser photocoagulation, pneumatic displacement of haemorrhage, vitreoretinal surgical techniques, the use of neodymium–doped yttrium aluminium garnet or argon laser, and intravitreal injections of anti–vascular endothelial growth factor drugs. Their precise roles should be evaluated in further studies.
Namen: Predstaviti dejavnike tveganja pri bolnikih, mlajših od 50 let, z zaporo mrežnične vene (RVO). Metode: Opravljena je bila retrospektivna analiza medicinske dokumentacije bolnikov z zaporo mrežnične vene od januarja 2015 do decembra 2020. Bolniki so bili mlajši od 50 let. Preučili smo podatke o sistemskih in očesnih obolenjih, zdravilih, trombofiliji ali hiperviskoznem sindromu in vaskulitisih. Vsi bolniki so imeli opravljen očesni in sistemski pregled, vključno z določitvijo testov trombofilije. Rezultati: V raziskavo je bilo zajetih 20 bolnikov (22 oči), od tega je bilo 15 moških (71 %) in 6 žensk (29 %). Povprečna starost bolnikov je bila 42 let. Pri 12 očeh (60 %) je bila ugotovljena zapora centralne mrežnične vene (CRVO), pri 10 očeh (40 %) pa zapora veje mrežnične vene (BRVO). Dva bolnika sta imela obojestransko BRVO. Arterijska hipertenzija je bila ugotovljena pri 8 bolnikih (38 %), sladkorna bolezen pri 2 bolnikih (9,5 %) in dislipidemija pri 11 bolnikih (52 %). Pri eni bolnici (5 %) je bila ugotovljena mutacija faktorja V Leiden. Pri 2 bolnikih z RVO sta bili diagnosticirani Behcetova (5 %) in Ealesova bolezen (5 %). 2 bolnika (10 %) sta imela pridružen pigmentni glavkom. Več dejavnikov tveganja je bilo prisotnih pri 10 bolnikih (48 %), medtem ko 4 bolniki niso imeli dejavnika tveganja (19 %). Zaključek: Najpogostejši dejavnik tveganja v naši raziskavi je bila dislipidemija. Trombofilija je bila ugotovljena le pri eni bolnici s CRVO. Pri mlajših bolnikih z RVO je pomembno pozorno preučiti dejavnike tveganja.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.